版本:
中国

BRIEF-CANCER GENETICS INC REPORTS Q1 LOSS PER SHARE $0.51

May 11 Cancer Genetics Inc

* CANCER GENETICS INC ANNOUNCES 15% REVENUE INCREASE IN FIRST QUARTER OF 2017 OVER 2016 ON STRONG ORGANIC GROWTH WHILE CONTINUING ON PATH TO PROFITABILITY

* Q1 LOSS PER SHARE $0.51

* Q1 REVENUE ROSE 15 PERCENT TO $7.0 MILLION

* Q1 ADJUSTED LOSS PER SHARE $0.11 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐